课题基金 / 基金详情

CIHR Team in Palmitoylation in Huntington Disease

CIHR Team in Palmitoylation in Huntington Disease
CIHR 团队在亨廷顿病棕榈酰化方面的研究
批准号:
188121
负责人:
Hayden Michael R
金额:
$181.43万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2009
资助国家:
加拿大
项目状态:
已结题
起止时间:
2009-06-01 至 2014-06-01

项目摘要

项目成果

Hayden Michael R的其他基金

相似基金

相关文献

中文摘要
翻译
蛋白质棕榈酰化是一种动态调节的翻译后修饰,对正确的细胞运输至关重要。我们最近的研究表明,棕榈酰化的缺陷,选定的神经元蛋白与亨廷顿病。我们将
英文摘要
Protein palmitoylation is a dynamically regulated posttranslational modification critical for proper cellular trafficking. Our recent studies show that defects in palmitoylation of selected neuronal proteins are associated with Huntington Disease. We will
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Allele-specific lowering of mutant polyQ proteins as treatment for Huntington disease, spinocerebellar ataxia type 3 and spinocerebellar ataxia type 7
Novel Approaches Directed to Prevention and Treatment of Huntington Disease
Canada Research Chair Tier 1
  • 批准号:
    315426
  • 项目类别:
  • 资助金额:
    $101.99万
  • 财政年份:
    2014
  • 负责人:
    Hayden Michael R
  • 依托单位:
Novel approaches to modulate key targets in the pathogenesis of Huntington Disease
海外基金